Table 3.
Univariate and multivariate Cox regression analyses for progression-free survival of the early-stage gastric MALT lymphoma patients.
| Characteristic | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR(95%CI) | P | HR(95%CI) | P | |
| Age | 1.03 (0.99-1.07) | 0.11 | 1.05(0.99-1.12) | 0.0902 |
| Anti-HP therapy | ||||
| No | Reference | Reference | ||
| Yes | 0.3 (0.11-0.82) | 0.02 | 0.91(0.23-3.62) | 0.8915 |
| Ectopic chromosome | ||||
| No | Reference | Reference | ||
| Unknow | 4.47 (0.57-34.94) | 0.154 | 3.65(0.14-32.38) | 0.2451 |
| Yes | 5.68 (0.66-48.69) | 0.113 | 8.25(0.83-82.04) | 0.0719 |
| LDH > UNL | ||||
| No | Reference | Reference | ||
| Yes | 5.28 (1.68-16.57) | 0.004 | 5.57(0.62-50.29) | 0.1262 |
| MALT IPI | ||||
| 0 | Reference | Reference | ||
| 1 | 3.16 (1.14-8.72) | 0.027 | 0.32(0.04-2.51) | 0.2768 |
| Ann Arbor stage | ||||
| I | Reference | Reference | ||
| II | 1.79 (0.67-4.78) | 0.243 | 2.56(0.82-7.98) | 0.1052 |
| First line treatment | ||||
| Pharmacotherapy | Reference | Reference | ||
| Radiotherapy | 0.12 (0.03-0.55) | 0.006 | 0.12(0.02-0.67) | 0.0152 |
| RT+PT | 0.05 (0.01-0.41) | 0.005 | 0.05(0.01-0.46) | 0.0077 |